Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Valneva SE
  6. News
  7. Summary
    VLA   FR0004056851

VALNEVA SE

(VLA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Valneva : reports positive results for its VLA2001 COVID vaccine candidate

10/18/2021 | 01:08am EST

PARIS, Oct 18 (Reuters) - Vaccine company Valneva reported on Monday positive Phase 3 results for its inactivated, adjuvanted COVID-19 vaccine candidate VLA2001, for which it is hoping to get a licence.

Valneva added it was preparing for trials in children aged between 5-12 years and for a Valneva sponsored booster trial to evaluate VLA2001’s booster performance for people in need of a COVID vaccine booster shot.

(Reporting by Sudip Kar-Gupta; Editing by Kim Coghill)


ę Reuters 2021
All news about VALNEVA SE
11/29Valneva, IDT Biologika to Collaborate Over COVID Vaccine
MT
11/29Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19..
AQ
11/26Health Care Stocks Slip But Outperform Broader Friday Markets as COVID Worries Re-Emerg..
MT
11/26VALNEVA : Signs Purchase Agreement with European Commission for its Inactivated COVID-19 V..
PU
11/26Top Premarket Gainers
MT
11/24Valneva CEO Slams UK for Surprise Cancellation of Vaccine Order in September
MT
11/24GLOBAL MARKETS LIVE : Valneva, Dell, HP, The Gap, Booking...
11/24EUROPEAN MIDDAY BRIEFING : Lockdown Worries Continue to Drag on Stocks
DJ
11/23France's Valneva Wins COVID-19 Vaccine Supply Deal With EU; Shares Up 7%
MT
11/23Valneva Signs Advance Purchase Agreement With EC for COVID-19 Vaccine Subject to Approv..
MT
More news
Analyst Recommendations on VALNEVA SE
More recommendations
Financials
Sales 2021 103 M 117 M 117 M
Net income 2021 -146 M -166 M -166 M
Net cash 2021 165 M 188 M 188 M
P/E ratio 2021 -19,7x
Yield 2021 -
Capitalization 2 992 M 3 372 M 3 400 M
EV / Sales 2021 27,4x
EV / Sales 2022 5,24x
Nbr of Employees 700
Free-Float 76,4%
Chart VALNEVA SE
Duration : Period :
Valneva SE Technical Analysis Chart | VLA | FR0004056851 | MarketScreener
Technical analysis trends VALNEVA SE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 28,48 €
Average target price 21,48 €
Spread / Average Target -24,6%
EPS Revisions
Managers and Directors
Thomas Lingelbach Co-President & Chief Executive Officer
Franck Charles Marie Grimaud Co-President & Chief Business Officer
Peter Buhler Chief Financial Officer & Director
FrÚdÚric Grimaud Chairman-Supervisory Board
Michael M÷hlen Vice President-Technical Development
Sector and Competitors
1st jan.Capi. (M$)
VALNEVA SE267.48%3 372
MODERNA, INC.252.74%149 412
LONZA GROUP AG28.41%58 671
IQVIA HOLDINGS INC.48.85%50 948
SEAGEN INC.-5.61%30 228
CELLTRION, INC.-40.81%24 321